The development and utility of a novel scale that quantifies the glycemic progression toward type 1 diabetes over 6 months.

Sosenko JM, Skyler JS, Beam CA, Boulware D, Mahon JL, Krischer JP, Greenbaum CJ, Rafkin LE, Matheson D, Herold KC, Palmer JP, Type 1 Diabetes TrialNet and Diabetes Prevention Trial–Type 1 Study Groups
Diabetes Care. 2015 38 (5): 940-2

PMID: 25758770 · PMCID: PMC4407750 · DOI:10.2337/dc14-2787

MeSH Terms (15)

Adolescent Autoantibodies Biomarkers Blood Glucose C-Peptide Diabetes Mellitus, Type 1 Disease Progression Female Glucose Tolerance Test Humans Hyperglycemia Male Patient Acuity Risk Factors Severity of Illness Index

Connections (2)

This publication is referenced by other Labnodes entities: